Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Ovid Therapeutics Inc OVID

Healthcare Biotechnology
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule... see more

Current News (NDAQ:OVID)

Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer

GlobeNewswire 9 days ago

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

GlobeNewswire November 12, 2025

Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds

GlobeNewswire October 3, 2025

Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile

GlobeNewswire October 3, 2025

Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results

GlobeNewswire August 13, 2025

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference

GlobeNewswire July 23, 2025

Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties

GlobeNewswire June 25, 2025

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025

GlobeNewswire June 5, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

GlobeNewswire May 13, 2025
View More News ››

Opinion & Analysis (NDAQ:OVID)

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Streetwise Reports September 25, 2019

Coverage Initiated on Biotech; Analyst Says, 'Time to Buy'

Streetwise Reports March 14, 2018
View More Opinion ››

Bullboard Posts (NDAQ:OVID)

Ovid Therapeutics Inc. (NASDAQ:OVID): A Promising Biopharmac

http://beyondspx.com/2024/08/01/ovid-therapeutics-inc-nasdaqovid-a-promising-biopharmaceutical-company-advancing-novel-therapies-for...
MikeTester - August 1, 2024

still holding this stock

it would be nice to have $5 to $6 per share for me,so glta shareholders.
coolfooldumbguy - September 25, 2019

Get ready for $ 12 US

https://seekingalpha.com/news/3501176-ovid-7-percent-positive-soticlestat-data
Biomed4077 - September 24, 2019

Get ready for $12 US

https://www.empr.com/home/mpr-first-report/aan-2019-coverage/ov101-gaboxadol-beneficial-in-adolescents-and-adults-with-angelman-syndrome/
Biomed4077 - September 24, 2019

still cheap at these prices

will add more next week,probably at the end of the month.
coolfooldumbguy - April 26, 2019

it's a buy today for me

at these low prices,so glta.
coolfooldumbguy - April 23, 2019
View more Bullboard ››

Sranan Gold Corp.

Sranan Gold Corp.

Sranan Gold Corp. develops, acquires, and explores mineral properties in Canada. The company primarily explores gold deposits ...
View More »